Blair Burnett

Blair Burnett supports clients with research and analysis that span a variety of healthcare sectors and stakeholders.

With experience in provider associations, management consulting, and advocacy groups, she assists clients with analysis on a range of federal health policy topics. Blair has particular expertise in policy issues related to oncology and Medicare Part B.

Prior to joining Avalere, Blair was senior policy analyst at the Association of Community Cancer Centers where she oversaw the legislative and regulatory advocacy priorities at the federal and state level for over 2,500 cancer care programs in the association’s membership. Prior to that, Blair was a healthcare analyst with Huron Consulting Group where she assisted clients in care access and revenue cycle projects.

Blair has a BA in public policy with a minor in information science from the University of North Carolina at Chapel Hill.

Authored Content

New Avalere analysis finds that practices currently participating in the Oncology Care Model (OCM) would be more likely to receive a Novel Therapy Adjustment (NTA) in the newly proposed Oncology Care First (OCF) Model.